Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 782.31%10.32K | 374.40%3.34K | 46.89%896 | -75.20%3.65K | 34.44%1.17K | -32.56%1.17K | -81.97%703 | -92.59%610 | -60.26%14.74K | -90.27%871 |
| Gross profit | -782.31%-10.32K | -374.40%-3.34K | -46.89%-896 | 75.20%-3.65K | -34.44%-1.17K | 32.56%-1.17K | 81.97%-703 | 92.59%-610 | 60.26%-14.74K | 90.27%-871 |
| Operating expense | 356.57%10.73M | 786.73%5.71M | 2.49%839.59K | -46.65%5.09M | -55.53%1.28M | -54.62%2.35M | 31.22%644.16K | -18.04%819.22K | 152.10%9.54M | 259.44%2.88M |
| Selling and administrative expenses | 154.27%988.61K | 202.51%679.55K | 44.91%370.68K | 2.81%1.29M | 27.92%422.79K | 27.31%388.8K | 2.80%224.64K | -36.41%255.79K | 11.21%1.26M | 24.32%330.52K |
| -General and administrative expense | 154.27%988.61K | 202.51%679.55K | 44.91%370.68K | 2.81%1.29M | 27.92%422.79K | 27.31%388.8K | 2.80%224.64K | -36.41%255.79K | 11.21%1.26M | 24.32%330.52K |
| Research and development costs | 35.25%186.72K | 194.35%137.47K | 138.94%126.88K | 43.91%423.63K | 220.22%185.76K | 47.51%138.06K | 11.45%46.7K | -47.35%53.1K | 10.81%294.37K | 726.13%58.01K |
| Other operating expenses | 424.05%9.55M | 1,212.96%4.89M | -32.98%342.03K | -57.76%3.38M | -73.06%670.07K | -61.86%1.82M | 61.76%372.81K | 2.80%510.32K | 234.41%7.99M | 357.68%2.49M |
| Operating profit | -356.78%-10.74M | -786.28%-5.72M | -2.52%-840.48K | 46.70%-5.1M | 55.51%-1.28M | 54.62%-2.35M | -30.33%-644.86K | 18.65%-819.83K | -150.04%-9.56M | -255.57%-2.88M |
| Net non-operating interest income (expenses) | 2,990.27%74.29K | 843.94%19.1K | 21.53%9.52K | -13.38%27.35K | 64.46%15.08K | -75.68%2.4K | -78.50%2.02K | 152.33%7.84K | 1,351.29%31.57K | 2,592.39%9.17K |
| Non-operating interest income | 2,990.27%74.29K | 843.94%19.1K | 21.53%9.52K | -13.94%27.35K | 64.46%15.08K | -75.68%2.4K | -78.54%2.02K | 138.00%7.84K | --31.78K | --9.17K |
| Non-operating interest expense | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -91.80%207 | --0 |
| Other net income (expenses) | 1,198.27%41.97K | -988.03%-42.47K | -301.49%-2.17K | 68.28%-22.71K | 52.40%-23.12K | 110.85%3.23K | -390.40%-3.9K | -80.11%1.08K | 60.39%-71.6K | 71.50%-48.56K |
| Gain on sale of security | 1,198.27%41.97K | -988.03%-42.47K | -301.49%-2.17K | -96.88%-22.71K | -528.33%-23.12K | 115.51%3.23K | -161.77%-3.9K | -80.11%1.08K | -442.21%-11.54K | -60.73%5.4K |
| Special income (charges) | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | 75.93%-60.06K | 78.37%-53.96K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -78.37%53.96K | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | ---6.1K | --0 |
| Income before tax | -352.92%-10.62M | -787.31%-5.74M | -2.74%-833.13K | 46.97%-5.09M | 55.83%-1.29M | 54.90%-2.35M | -33.61%-646.74K | 18.84%-810.92K | -139.60%-9.6M | -197.61%-2.92M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -352.92%-10.62M | -787.31%-5.74M | -2.74%-833.13K | 46.97%-5.09M | 55.83%-1.29M | 54.90%-2.35M | -33.61%-646.74K | 18.84%-810.92K | -139.60%-9.6M | -197.61%-2.92M |
| Net income continuous operations | -352.92%-10.62M | -787.31%-5.74M | -2.74%-833.13K | 46.97%-5.09M | 55.83%-1.29M | 54.90%-2.35M | -33.61%-646.74K | 18.84%-810.92K | -139.60%-9.6M | -197.61%-2.92M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -352.92%-10.62M | -787.31%-5.74M | -2.74%-833.13K | 46.97%-5.09M | 55.83%-1.29M | 54.90%-2.35M | -33.61%-646.74K | 18.84%-810.92K | -139.60%-9.6M | -197.61%-2.92M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -352.92%-10.62M | -787.31%-5.74M | -2.74%-833.13K | 46.97%-5.09M | 55.83%-1.29M | 54.90%-2.35M | -33.61%-646.74K | 18.84%-810.92K | -139.60%-9.6M | -197.61%-2.92M |
| Diluted earnings per share | -100.00%-0.14 | -450.00%-0.11 | 0.00%-0.02 | 66.67%-0.1 | 0.01 | 65.00%-0.07 | -0.15%-0.02 | 51.96%-0.02 | -50.00%-0.3 | 0 |
| Basic earnings per share | -100.00%-0.14 | -450.00%-0.11 | 0.00%-0.02 | 66.67%-0.1 | 0.01 | 65.00%-0.07 | -0.15%-0.02 | 51.96%-0.02 | -50.00%-0.3 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.